Matjaž Sever

1.4k total citations
52 papers, 984 citations indexed

About

Matjaž Sever is a scholar working on Genetics, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Matjaž Sever has authored 52 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 18 papers in Surgery and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Matjaž Sever's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Cardiac Structural Anomalies and Repair (9 papers) and Mechanical Circulatory Support Devices (9 papers). Matjaž Sever is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Cardiac Structural Anomalies and Repair (9 papers) and Mechanical Circulatory Support Devices (9 papers). Matjaž Sever collaborates with scholars based in Slovenia, United States and Slovakia. Matjaž Sever's co-authors include Peter Černelč, Gregor Poglajen, Bojan Vrtovec, François Haddad, Luka Ležaić, Joseph C. Wu, Dragoslav Domanović, Guillermo Torre‐Amione, Aljaž Sočan and Srđan Verstovšek and has published in prestigious journals such as Circulation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Matjaž Sever

45 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matjaž Sever Slovenia 15 430 373 365 228 136 52 984
Gunter Kerst Germany 18 228 0.5× 298 0.8× 222 0.6× 370 1.6× 190 1.4× 64 1.2k
Carmelo Panetta United States 12 650 1.5× 392 1.1× 234 0.6× 285 1.3× 74 0.5× 26 1.2k
María Jesús Peñarrubia Spain 12 329 0.8× 219 0.6× 327 0.9× 98 0.4× 172 1.3× 28 731
James J.H. Chong Australia 18 767 1.8× 759 2.0× 207 0.6× 469 2.1× 141 1.0× 76 1.6k
Akihito Mikamo Japan 17 601 1.4× 385 1.0× 368 1.0× 265 1.2× 22 0.2× 69 1.1k
Stephan Söder Germany 19 177 0.4× 326 0.9× 78 0.2× 118 0.5× 164 1.2× 57 1.2k
Dylan V. Miller United States 12 262 0.6× 239 0.6× 100 0.3× 125 0.5× 25 0.2× 18 792
B Descamps France 14 224 0.5× 609 1.6× 198 0.5× 80 0.4× 31 0.2× 29 1.1k
Meindert J. Crop Netherlands 12 394 0.9× 220 0.6× 648 1.8× 28 0.1× 69 0.5× 18 916
David L. Amrani United States 13 307 0.7× 345 0.9× 201 0.6× 106 0.5× 124 0.9× 24 921

Countries citing papers authored by Matjaž Sever

Since Specialization
Citations

This map shows the geographic impact of Matjaž Sever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matjaž Sever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matjaž Sever more than expected).

Fields of papers citing papers by Matjaž Sever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matjaž Sever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matjaž Sever. The network helps show where Matjaž Sever may publish in the future.

Co-authorship network of co-authors of Matjaž Sever

This figure shows the co-authorship network connecting the top 25 collaborators of Matjaž Sever. A scholar is included among the top collaborators of Matjaž Sever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matjaž Sever. Matjaž Sever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Blinc, Aleš, et al.. (2024). Relation of JAK2 V617F allele burden and coronary calcium score in patients with essential thrombocythemia. Radiology and Oncology. 58(4). 565–572. 1 indexed citations
3.
Frol, Senta, Janja Pretnar Oblak, Mišo Šabović, Pawel Kermer, & Matjaž Sever. (2023). Treatment of Acute Ischaemic Stroke and Concomitant Multiple Arterial Splanchnic Thromboses in a Patient with Immune Thrombocytopenia on Thrombopoietin Agonist: A Case Report. Neurology International. 15(3). 1191–1199.
4.
Večerić‐Haler, Željka, Matjaž Sever, Nika Kojc, et al.. (2022). Autologous Mesenchymal Stem Cells for Treatment of Chronic Active Antibody-Mediated Kidney Graft Rejection: Report of the Phase I/II Clinical Trial Case Series. Transplant International. 35. 10772–10772. 11 indexed citations
5.
Vrtovec, Bojan, Gregor Poglajen, A. Cerar, et al.. (2022). A pilot clinical trial of cell therapy in heart failure with preserved ejection fraction. European Journal of Heart Failure. 24(8). 1441–1449. 4 indexed citations
6.
7.
Fink, Martina, et al.. (2021). Diagnosis and management of non-clonal erythrocytosis remains challenging: a single centre clinical experience. Annals of Hematology. 100(8). 1965–1973. 9 indexed citations
8.
Večerić‐Haler, Željka, Nika Kojc, Matjaž Sever, et al.. (2021). Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy. Frontiers in Medicine. 8. 708744–708744. 8 indexed citations
9.
Podgornik, Helena, et al.. (2020). Genetic Variant Detection in the <em>CALR</em> gene using High Resolution Melting Analysis. Journal of Visualized Experiments. 2 indexed citations
10.
11.
Mijovski, Mojca Božič, et al.. (2020). Progression of coronary calcium burden and carotid stiffness in patients with essential thrombocythemia associated with JAK2 V617F mutation. Atherosclerosis. 296. 25–31. 13 indexed citations
12.
Sever, Matjaž, et al.. (2019). CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms. Scientific Reports. 9(1). 19838–19838. 13 indexed citations
13.
14.
Vrtovec, Bojan, Matjaž Sever, Mojca Jensterle, et al.. (2016). Efficacy of CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Is Absent in Patients With Diabetes but Preserved in Patients With Insulin Resistance. Stem Cells Translational Medicine. 5(5). 632–638. 29 indexed citations
15.
Gašljević, Gorana, et al.. (2015). Hodgkin’s lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis. Diagnostic Pathology. 10(1). 5–5. 3 indexed citations
16.
Ležaić, Luka, Aljaž Sočan, Gregor Poglajen, et al.. (2014). Intracoronary Transplantation of CD34+ Cells Is Associated With Improved Myocardial Perfusion in Patients With Nonischemic Dilated Cardiomyopathy. Journal of Cardiac Failure. 21(2). 145–152. 42 indexed citations
17.
Quintás‐Cardama, Alfonso, Matjaž Sever, Jörge E. Cortes, Hagop M. Kantarjian, & Srđan Verstovšek. (2013). Bone marrow mast cell burden and serum tryptase level as markers of response in patients with systemic mastocytosis. Leukemia & lymphoma. 54(9). 1959–1964. 8 indexed citations
18.
Sever, Matjaž, Alfonso Quintás‐Cardama, Sherry Pierce, et al.. (2013). Significance of cytogenetic abnormalities in patients with polycythemia vera. Leukemia & lymphoma. 54(12). 2667–2670. 16 indexed citations
19.
Vrtovec, Bojan, Matjaž Sever, Dragoslav Domanović, et al.. (2012). Long-term effects of stem cell transplantation in heart failure. SHILAP Revista de lepidopterología. 3 indexed citations
20.
Vrtovec, Bojan, Matjaž Sever, Dragoslav Domanović, et al.. (2012). Dolgoročni učinki presaditve matičnih celic pri bolnikih s srčnim popuščanjem. 81. 373–383. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gunter Kerst Breakdown of academic impact, for papers by Carmelo Panetta Breakdown of academic impact, for papers by María Jesús Peñarrubia Breakdown of academic impact, for papers by James J.H. Chong Breakdown of academic impact, for papers by Akihito Mikamo Breakdown of academic impact, for papers by Stephan Söder Breakdown of academic impact, for papers by Dylan V. Miller Breakdown of academic impact, for papers by B Descamps Breakdown of academic impact, for papers by Meindert J. Crop Breakdown of academic impact, for papers by David L. Amrani
Rankless by CCL
2026